ArticleProstate cancer and prostatic diseases2015

Prospective evaluation of low-dose ketoconazole plus hydrocortisone in docetaxel pre-treated castration-resistant prostate cancer patients.

E N Lo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.